The activity of Ro 15-8074/001 was compared with that of cefaclor, amoxicillin-clavulanic acid, trimethoprim-sulfamethoxazole, norfloxacin, and ceftriaxone against 225 clinical isolates. It was more active than cefaclor, amoxicillin-clavulanic acid, and trimethoprim-sulfamethoxazole against members of the family Enterobacteriaceae and Haemophilus influenzae and had activity similar to that of cefaclor against nonenterococcal streptococci. It was not usefully active against Pseudomonas aeruginosa, Streptococcusfaecalis, or most isolates of staphylococci.
Ro 15-8075 (Fig. 1A) is the pivaloylomethoxyester of an aminothiazolyl cephalosporin. After oral administration and absorption the ester group is enzymatically split to produce the free acid Ro 15-8074 (Fig. 1B) . Peak levels in serum of 5 ,ug of Ro 15-8074 per ml are achieved following oral administration of 1 g of Ro 15-8075, and 80 to 100% of the free acid is excreted in the urine over the first 24 h. When administered to mice with experimental infections due to a range of gram-positive or -negative organisms, curative doses for 50% (of mice) of Ro 15-8075 were 5 to 100 times lower than those of cephalexin (data on file, F. Hoffmann-La Roche and Co. Ltd., Basel, Switzerland). We used the sodium salt (Ro 15-8074/001) of the free acid to compare the activity of this compound with that of four other oral antibiotics and ceftriaxone against a variety of bacteria.
Ro 15-8074/001 was a gift from F. Hoffman-La Roche. All other antibiotics were donated by their respective manufacturers. Antimicrobial activity was determined by an agar dilution method with fresh serial dilutions of compounds prepared according to the instructions of the manufacturer. The inoculum was prepared from a fresl overnight broth culture adjusted to a McFarland 0.5 standard and then diluted to deliver 105 CFU with a replicating spot device. Haemophilus influenzae and nonenterococcal streptococci were tested on Mueller-Hinton agar supplemented with 5% chocolatized horse blood and 1% IsoVitaleX (BBL Microbiology Systems, Cockeysville, Md.) incubated in 8% C02 at 37°C for 18 h. All other isolates were tested on MuellerHinton agar incubated in air at 37°C for 18 h. Serial dilutions of trimethoprim-sulfamethoxazole (TMP-SMX) were supplemented with 5% lysed horse blood. Susceptibility to amoxicillin-clavulanic acid was determined by using a constant ratio of amoxicillin to clavulanic acid of 2:1.
The The comparative activity of the six antimicrobial agents tested are summarized in Table 1 . Ro 15-8074/001 inhibited 98 isolates (79%) of members of the family Enterobacteriaceae at concentrations <1.0 ,ug/ml and 119 isolates (96%) at concentrations .8.0 p g/ml. In contrast cefaclor inhibited 35 isolates (28%) of Enterobacteriaceae at concentrations .1.0 pug/ml and 85 isolates (69%) at concentrations .8.0 pug/ml. Of the 39 cefaclor-resistant (MIC, .16 ,ug/ml) Enterobacteriaceae isolates, 34 (87%) were inhibited by .8.0 ,ug of Ro 15-8074/001 per ml. In general, Ro 15-8074/001 was more active than amoxicillin-clavulanic acid and TMP-SMX but less active than norfloxacin against-the Enterobacteriaceae. It had a similar spectrum of activity to ceftriaxone, but MICs of ceftriaxone were usually two to three log2 dilutions lower.
Ro 15-8074/001 was not active against P. aeruginosa (11 isolates; MIC, -256). It was more active than cefaclor against Acinetobacter sp. and was more active than cefaclor, amoxicillin-clavulanic acid, and TMP-SMX against H. influenzae.
Ro 15-8074/001 had poor activity against staphylococci and Streptococcus faecalis (10 isolates; MIC, 16 to .256). Its activity against Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae was similar,to that of cefaclor and greater than that of TMP-SMX and norfloxacin. In general amoxicillin-clavulanic acid was the most active agent against staphylococci and streptococci.
MICs of Ro 15-8074/001 for control organisms were 0.5 ,ug/ml for E. coli ATCC 35218 and E. coli NCTC 11560; 0.5 to 1.0 p,g/ml for E. coli ATCC 25922; 16 pig/ml for S. aureus ATCC 25923; 32 pug/ml for S. aureus NCTC 11561; and .256 ,ug/ml for P. aeruginosa ATCC 27853.
The results of this study indicate that Ro 15-8074/001 is an effective antimicrobial agent against routine isolates of members of the family Enterobacteriaceae, H. influenzae, and nonenterococcal streptococci. Other workers have found that Ro 15-8074/001 is more active than cefaclor, cefadroxil, ampicillin, and TMP-SMX against the Enterobacteriaceae (2) and more active than amoxicillin-clavulanic acid and cefaclor against pencillinase-producing and nonpenicillinaseproducing Neisseria gonorrhoeae (1) . Further studies are indicated to determine the clinical efficacy of this new oral cephalosporin.
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